|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5377 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 16/00 | (2006.01) | ||
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 3585437 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18707340.8 |
| Date of filing the European patent application | 2018-02-22 | |
| (97) | Date of publication of the European application | 2020-01-01 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/054376 |
| Date | 2018-02-22 |
| (87) | Number | WO 2018/153980 |
| Date | 2018-08-30 |
| (30) | Number | Date | Country code |
| 17157835 | 2017-02-24 | EP |
| (72) |
NINGSHU, Liu , DE
|
| (73) |
Bayer Pharma Aktiengesellschaft ,
Müllerstrasse 178, 13353 Berlin,
DE
|
| (54) | COMBINATIONS OF COPANLISIB WITH ANTI-PD-1 ANTIBODY |
| COMBINATIONS OF COPANLISIB WITH ANTI-PD-1 ANTIBODY |